A new JAMA Network Open study found a small difference in REM sleep among children with documented melatonin use, while most other measured sleep outcomes were similar. Here is what parents should know and what the research does not prove.

Editorial Note

This article is provided for general educational and health-literacy purposes. It does not provide medical advice or recommend starting, stopping, increasing, or reducing melatonin for any child. Parents and caregivers should discuss persistent sleep problems and the use of melatonin or other sleep products with a qualified pediatric health professional.

The study discussed here is observational. It identified an association between documented outpatient melatonin use and a small difference in REM sleep, but it cannot establish that melatonin caused that difference. The researchers called for prospective studies that document dose, timing, formulation, and actual use before stronger conclusions can be drawn.

A Common Sleep Aid Is Raising a More Complicated Question

Melatonin has become familiar to many families. Gummies, liquids, chewable tablets, and capsules are widely available, and the supplement can easily become part of a household conversation when a child has trouble falling asleep.

For many parents, the question has traditionally been simple: Does melatonin help my child get to sleep?

A study published August 6, 2026, in JAMA Network Open asks something more complicated. Researchers wanted to know what children’s actual sleep architecture looked like among those with documented melatonin use.

Instead of relying only on parent reports or asking how quickly children appeared to fall asleep, the researchers analyzed polysomnography, the detailed overnight testing commonly known as a sleep study.

Their main finding was notable but modest. Children with documented outpatient melatonin use spent a slightly smaller percentage of their sleep in rapid eye movement, or REM, sleep than carefully matched children without documented melatonin use.

Most of the other sleep measurements researchers examined, however, did not significantly differ.

That combination is exactly why the study deserves careful discussion rather than a frightening headline.

What Researchers Actually Studied

The researchers used the Nationwide Children’s Hospital Sleep DataBank, which contains overnight sleep-study recordings linked with electronic health information from children evaluated at an academic pediatric sleep laboratory between 2017 and 2019.

The initial analytic group included 3,392 children, with an average age of approximately 8 years. Among them, 346 had outpatient medication records documenting melatonin use.

Researchers then used a statistical method called propensity-score matching to create groups that were more comparable. The principal analysis involved 684 children: 342 with documented melatonin use and 342 matched nonusers.

The matching process considered factors including age, sex, body-mass-index percentile, overall medical conditions, obstructive sleep apnea, and epilepsy.

That matters because children taking melatonin may already be different from children who do not use it. They may have different medical conditions, different sleep problems, or other characteristics that could influence their sleep independently of melatonin.

The researchers’ primary outcome was the percentage of the night spent in REM sleep. They also examined 14 other measurements involving total sleep time, sleep efficiency, other sleep stages, breathing during sleep, awakenings, oxygen desaturation, and periodic limb movements.

In other words, the study was not merely asking whether melatonin users slept longer. It was examining what happened inside their sleep.

The Main Finding: A Small Difference in REM Sleep

Among the matched children, those with documented melatonin use spent a median 16.7% of their sleep in REM, compared with 19.0% among matched nonusers.

That represents a difference of approximately 2.3 percentage points.

The researchers characterized the magnitude as small, and they were careful not to claim that the difference was harmful.

When researchers conducted additional analyses accounting for psychiatric diagnoses such as ADHD, anxiety, and depression, the association became smaller. An accompanying JAMA Network Open commentary also noted that further adjustment for psychiatric diagnoses and concurrent sleep medications weakened the REM signal.

This illustrates one of the central challenges of observational research. People taking a medication or supplement may differ from nonusers in ways that are difficult to completely account for statistically.

The study therefore cannot tell us that melatonin directly reduced REM sleep. It tells us that researchers observed a relationship worth investigating.

Those are very different conclusions.

Most Other Sleep Measurements Were Similar

The REM result will understandably attract the most attention, but parents should also know what researchers did not find.

After correcting for multiple statistical comparisons, the melatonin and non-melatonin groups did not significantly differ across the other 14 exploratory sleep measures.

Those measurements included total sleep time, sleep efficiency, non-REM sleep stages, respiratory measurements, arousal patterns, periodic limb movements, and oxygen desaturation.

Median total sleep time was approximately 392 minutes among children with documented melatonin use and 396 minutes among matched nonusers. Sleep efficiency was essentially identical between the groups.

This produces a much more nuanced picture than a headline claiming that melatonin “disrupts children’s sleep.”

The study did not identify widespread differences throughout sleep architecture. It found one relatively small REM-related association whose clinical importance remains unknown.

The accompanying commentary made a similar point: the study provides valuable information, but it should not be treated as a final answer about whether repeated melatonin use is safe during childhood.

Why REM Sleep Gets Scientists’ Attention

Sleep is not one continuous state from bedtime until morning.

Throughout the night, the brain moves through different stages of non-REM and REM sleep. Those stages are associated with different neurological and physiological processes.

REM sleep is particularly interesting because it has been associated with learning, emotional processing, memory consolidation, and neurodevelopment.

That makes a measurable REM difference scientifically worth examining, especially in children whose brains are still developing.

But a scientifically measurable difference is not automatically a clinically meaningful one.

Researchers do not yet know whether the approximately 2.3-percentage-point difference observed in this study has any meaningful effect on children’s learning, behavior, emotional regulation, development, or health.

A statistical difference can exist without producing a noticeable health consequence. At the same time, researchers reasonably want to know whether a small difference repeated over long periods of development could eventually matter.

This particular study cannot answer that question.

This Was Not a Trial Where Researchers Gave Children Melatonin

Understanding the design of the study is crucial.

Researchers did not randomly assign some children to take melatonin and others to receive a placebo and then compare their sleep.

They analyzed existing medical and sleep-laboratory records and compared children whose outpatient medication lists documented melatonin with matched children without documented use.

That makes the research a cross-sectional observational study, not a randomized clinical trial.

The researchers also lacked several pieces of information that would be necessary to determine exactly how melatonin might affect sleep. They did not have complete documentation of the child’s dose, formulation, timing relative to bedtime, duration of use, or whether the child actually took melatonin on the night of the sleep study.

The medication records could also miss over-the-counter melatonin use among children classified as nonusers.

Those limitations matter.

A child taking a small amount occasionally is not necessarily comparable with a child taking a larger amount every night. Immediate-release and extended-release products may also behave differently, and taking melatonin at different points in a child’s circadian cycle could potentially produce different effects.

Future studies will need much more precise exposure information.

These Children Were Already Being Evaluated in a Sleep Laboratory

The study population was not a random sample of children from schools or communities across the United States.

These were children referred to a pediatric sleep laboratory.

Children undergoing polysomnography may have sleep-disordered breathing, obesity, neurological conditions, neurodevelopmental differences, epilepsy, or other medical concerns more frequently than children in the general population.

That means researchers must be cautious about applying the findings to every child who occasionally takes melatonin at home.

At the same time, the sleep-laboratory setting provides one of the study’s greatest strengths. Polysomnography allows researchers to objectively examine sleep stages rather than depending entirely on questionnaires, parent observations, or wearable-device estimates.

The measurements are detailed, but the population is specialized. Both facts matter when interpreting the research.

Melatonin Is Not Simply a Conventional Sleeping Pill

Melatonin is naturally produced by the body and plays an important role in circadian timing, the biological system that helps regulate when we feel awake and when we become sleepy.

Supplemental melatonin can influence that timing.

That is why the American Academy of Pediatrics emphasizes that melatonin should not simply be treated like an ordinary sleeping pill.

AAP guidance recommends discussing melatonin use with a child’s pediatrician and establishing healthy sleep habits before relying on a supplement. Melatonin may have a role for some children, including certain children with neurodevelopmental conditions, but decisions about its use should be individualized.

American Academy of Pediatrics — Melatonin for Kids: What Parents Should Know

The larger lesson is that availability does not necessarily equal simplicity.

A product being available without a prescription does not mean it is appropriate for every child, every sleep problem, every night, or every developmental stage.

Long-Term Evidence Remains an Important Gap

The new REM study is not the only recent research showing what scientists still need to understand.

A separate 2026 systematic review in JAMA Network Open evaluated 19 publications involving melatonin use in children ages 6 years and younger.

Researchers found evidence that melatonin could improve sleep onset in some young children with neurological conditions. However, they also identified substantial gaps in longer-term outcome data and found no efficacy trials for typically developing young children in the evidence they reviewed.

JAMA Network Open — Melatonin Use in Young Children: A Systematic Review

This distinction matters because discussions about health research frequently confuse two very different ideas.

Evidence that something causes long-term harm is not the same as researchers lacking enough long-term evidence to confidently determine its effects.

Current research leaves important questions unanswered. That uncertainty should neither be exaggerated into proof of danger nor ignored as if the questions have already been settled.

Accidental Ingestion Is a Separate Safety Concern

Questions about REM sleep should also be separated from another pediatric melatonin issue: accidental ingestion.

According to the American Academy of Pediatrics, more than 260,000 pediatric melatonin poisoning reports occurred between 2012 and 2021. Most children had no symptoms and recovered, but some required hospital care, and severe outcomes were reported.

Products sold as gummies or chewables may be especially attractive to young children because they can resemble candy.

Whatever researchers ultimately determine about long-term sleep architecture, the storage issue is much more straightforward.

Melatonin should be treated like other medications and supplements and stored somewhere young children cannot independently access it.

Parents should also know exactly what product is being used rather than assuming that every melatonin supplement contains the same formulation or amount.

Before Asking About Melatonin, Ask Why a Child Is Not Sleeping

Perhaps the most useful question comes before deciding whether a sleep supplement is appropriate.

Why is the child having trouble sleeping?

There are many possible answers.

An inconsistent bedtime schedule can contribute. Screens and bright light late at night can interfere with sleep timing. Teenagers’ natural circadian rhythms can make early bedtimes difficult. Stress and anxiety may keep a child awake, while caffeine can remain active much later than families realize.

Snoring, breathing problems, medications, neurological conditions, mental-health concerns, or other medical issues may also affect sleep.

Treating every difficult bedtime as a simple need for melatonin risks overlooking the reason sleep is difficult in the first place.

The American Academy of Pediatrics recommends consistent bedtime routines and limiting screen exposure before sleep. It also advises families to speak with their pediatrician when sleep difficulties persist despite healthy routines.

AAP Guidance on Children’s Sleep and Melatonin

The goal should not be to make families feel guilty for having used melatonin. The goal should be to make the decision more thoughtful.

Sleep Is an Education Issue Too

This research belongs in an education conversation because sleep is closely connected to children’s ability to function during the school day.

Healthy sleep supports attention, learning, memory, behavior, and emotional regulation. A student who is chronically tired may struggle to concentrate, retain new information, regulate frustration, or remain alert through morning classes.

What adults interpret as laziness, lack of motivation, or poor behavior can sometimes be influenced by inadequate or poorly timed sleep.

That does not mean every academic or behavioral problem is caused by sleep. It means sleep is part of the infrastructure supporting learning.

That is one reason the new melatonin research is more interesting than simply asking whether a gummy helps a child fall asleep faster.

The goal is not merely getting a child to sleep for several hours. The goal is restorative sleep that supports a developing brain and body.

Understanding sleep architecture gives researchers another way to investigate whether commonly used sleep interventions are helping achieve that goal.

What the Study Actually Tells Parents

The study gives families and clinicians a useful new piece of information.

Among children evaluated in a pediatric sleep laboratory, documented melatonin use was associated with a small reduction in the percentage of sleep spent in REM. Researchers did not find significant differences across most of the other objective sleep measurements they examined.

The research does not demonstrate that melatonin damages children’s brains, causes learning problems, creates developmental delays, or produces another specific health consequence. It also does not prove that melatonin caused the observed REM difference.

At the same time, the lack of major differences in other sleep measurements should not be interpreted as proof that every pattern of pediatric melatonin use is completely understood or risk-free.

The most accurate conclusion sits between those extremes.

The study provides another piece of evidence that deserves further research rather than a final verdict on pediatric melatonin.

What Researchers Need to Study Next

Future research will need to track children prospectively and document exactly what they are taking.

Researchers need reliable information about melatonin dose, formulation, timing, frequency, duration of use, and whether children actually take the supplement as recorded.

Developmental stage may also be important.

A preschool child, an elementary-age student, and a teenager have different sleep needs, hormonal development, circadian rhythms, school schedules, and neurological development. It would be surprising if every child responded identically to the same intervention.

Researchers also need to determine whether any measurable difference in sleep architecture corresponds with outcomes families actually care about, including daytime alertness, learning, memory, emotional health, behavior, and development.

The accompanying JAMA Network Open commentary argues for this more individualized approach. Rather than treating melatonin as universally good or universally bad, future research should help determine which children may benefit, under what circumstances, at what dose and timing, and for how long.

That question is far more useful than simply asking whether melatonin is “safe” or “unsafe.”

Key Takeaways

A new JAMA Network Open study examined objective overnight sleep measurements in 684 propensity-score-matched children, including 342 with documented outpatient melatonin use and 342 matched nonusers.

Children with documented melatonin use spent a median 16.7% of their sleep in REM, compared with 19.0% among matched nonusers. Researchers described the difference as small, and its clinical significance remains uncertain.

After statistical correction, the study did not identify significant differences across the other 14 exploratory sleep measures, including total sleep time, sleep efficiency, non-REM stages, breathing measurements, arousals, oxygen desaturation, and periodic limb movements.

Most importantly, the study was observational. It cannot establish that melatonin caused the REM difference, and researchers lacked complete information about dose, timing, formulation, duration, and adherence.

For families, the appropriate takeaway is neither panic nor dismissal. The findings add another reason for thoughtful pediatric guidance and better long-term research.

FAQ

Did the study prove that melatonin reduces REM sleep in children?

No. Researchers found an association between documented melatonin use and a small reduction in REM sleep percentage. Because the study was observational, it cannot prove that melatonin caused the difference.

How large was the REM difference?

Children with documented melatonin use spent a median 16.7% of sleep in REM, compared with 19.0% among matched nonusers, a difference of approximately 2.3 percentage points.

Did children using melatonin sleep longer?

Not significantly in this study. Median total sleep time was approximately 392 minutes among documented melatonin users and 396 minutes among matched nonusers.

Should parents stop giving their children melatonin because of this study?

The research does not make that recommendation. Parents should not start, stop, or change a child’s melatonin use based solely on one observational study. The American Academy of Pediatrics recommends discussing pediatric melatonin use with a child’s healthcare professional.

Is melatonin safe for children?

There is no single answer that applies to every child. Evidence and recommendations depend on a child’s age, medical circumstances, reason for use, dose, timing, and duration. Short-term use may be appropriate in some circumstances, while important questions remain about routine and long-term use.

Why does REM sleep matter?

REM sleep is associated with processes involving learning, memory, emotional processing, and neurological development. Researchers do not yet know whether the small REM difference observed in this study produces any meaningful health or developmental effect.

Final Thoughts

The most valuable part of this new research may be that it changes the conversation around children’s sleep.

Families often focus on one immediate outcome: Did the child fall asleep?

That question matters, especially when bedtime has become stressful or when a child has a condition that makes sleep particularly difficult. But falling asleep is only one part of healthy sleep.

The brain moves through a complicated sequence of sleep stages throughout the night. Those stages are connected with memory, emotion, restoration, and development. Researchers are still working to understand whether supplemental melatonin meaningfully changes those processes during childhood.

The new study offers some reassurance because broad differences were not observed across most measured aspects of sleep. At the same time, the small REM association gives researchers a reason to investigate further rather than assuming every question about pediatric melatonin has already been answered.

Parents do not need alarmist headlines telling them that a common supplement is suddenly dangerous. They also do not need false reassurance that widespread availability automatically means every type of use has been thoroughly studied.

They need something more useful: accurate information, sensible sleep habits, appropriate medical guidance, safe storage, and research that clearly separates what scientists know from what they are still trying to understand.

When it comes to melatonin and developing children, there is still more to learn.

Support New To Education

New To Education publishes research-based educational content designed to help students, families, educators, and lifelong learners better understand developments in health, education, science, technology, financial literacy, and everyday life.

Support New To Education by sharing our work and helping more families access clear, practical, student-centered educational information.

How to Build a Better Sleep Routine: Simple Habits That Actually Help

Stop Calling Teen Exhaustion Laziness